Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

There Is No Exception From Arthrex For Ex Parte Proceedings

By John Isacson on July 7, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

In re Boloro Global Ltd., Appeal Nos. 2019-2349, -2351 and -2353 (Fed. Cir., July 7, 2020).

Boloro appealed to the PTAB final rejections in three patent applications, which the PTAB ultimately affirmed. On appeal of the PTAB decisions to the Federal Circuit, Boloro moved to vacate the PTAB decisions and remand the appeals to different panels of the PTAB.

The Director opposed the motions to vacate and remand on the grounds that the Director “possesses ‘complete control over initial examination’ and could at any time prior to the Board proceedings have directed the issuance of Boloro’s patents but did not, consistent with the Board’s subsequent decisions.” Slip op. at 2-3. The Federal Circuit was not persuaded and granted Boloro’s motions. The court noted that the Director conceded that the APJ’s appointed were unconstitutional, and thus the was no basis to depart from the general rule. Accordingly, no matter the type of proceeding, any PTAB decision issued before Arthrex and under appeal is subject to vacatur and remand.

Photo of John Isacson John Isacson

A registered patent attorney, John has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, biosimilars, and Hatch-Waxman. He is regularly involved in litigation and U.S. Patent…

A registered patent attorney, John has particular experience in strategic counseling and patent portfolio management, infringement litigation, due diligence, inter partes and post-grant reviews, reexaminations, patent interferences, inventorship and ownership disputes, biosimilars, and Hatch-Waxman. He is regularly involved in litigation and U.S. Patent and Trademark Office proceedings. John also advises on related FDA matters for certain technologies.

Read more about John IsacsonEmailJohn's Linkedin Profile
Show more Show less
  • Posted in:
    Intellectual Property
  • Blog:
    PostGrant-Counsel Blog
  • Organization:
    Troutman Pepper Hamilton Sanders LLP

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • Pro Policyholder
  • The Way on FDA
  • Crypto Digest
  • Inside Cybersecurity & Privacy Law
  • La Oficina Legal Ayala Hernández
Copyright © 2022, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo